Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Teriparatide by Entera Bio for Hypoparathyroidism: Likelihood of Approval
Teriparatide is under clinical development by Entera Bio and currently in Phase II for Hypoparathyroidism. According to GlobalData, Phase II...
Data Insights
Teriparatide by Corium for Osteoporosis: Likelihood of Approval
Teriparatide is under clinical development by Corium and currently in Phase II for Osteoporosis. According to GlobalData, Phase II drugs...